Click it and Unblock the Notifications
For Quick Alerts
For Daily Alerts
Just In
Don't Miss
-
Tohfa, Tohfa, Tohfa: Tata's NBFC To Power; 9 Tata Group Stocks To Pay Massive Dividends In Coming Weeks -
What Is 'Dry Promotion' Trend? Why Should Employees Be Concerned? -
Who is Aparna Thakur? Ravi Kishan's Alleged Second Wife Who Sued Bhojpuri Star, Marriage Details & More -
Dharamshala Stadium Embraces Cutting-Edge SISGrass Hybrid Pitch Technology To Revolutionise Indian Cricket -
From Coconut Breaking on Head to Men Dressing as Women: 12 Unique Indian Rituals Explored -
ASUS Zenbook DUO 2024 Launched in India – Check Price, Specs, Where to Buy -
Renault Duster And Nissan Models To Feature Turbo-Petrol Engines: Hybrid In The Makes? -
TN MRB Assistant Surgeon Recruitment 2024; 2553 Vacancies, Application Procedure Selection Details and more
Shasun Chem licenses drug technology to US' Merck
New Delhi, Feb 27 (UNI) Shasun Chemicals and Drugs Ltd today said it has signed a non-exclusive deal with US-based Merck and Co to allow the use of its proprietary technology to make bulk drugs.
''Shasun has granted Merck the use of its proprietary cross-coupling copper technology (also known as Buchwald technology) to manufacture and commercialise API's (Active Pharmaceutical Ingredients),'' said a company statement.
The technology allows complex new drugs to be manufactured in an efficient and economical way.
UNI
SR
MP
DS1533
Comments
Story first published: Friday, February 29, 2008, 12:00 [IST]
